Rexgen came into being in 2020 as a company enlisted under no 12606494, located at NW4 4AU London at Stirling House. This firm has been in business for 4 years and its current status is active. This business's principal business activity number is 72110 and their NACE code stands for Research and experimental development on biotechnology. Rexgen Limited released its account information for the financial year up to May 31, 2023. The latest annual confirmation statement was submitted on July 20, 2023.
Concerning this particular business, the full extent of director's duties have so far been done by Marco C. who was appointed in 2020 in May.
Marco C. is the individual who has control over this firm, owns 1/2 or less of company shares and has 1/2 or less of voting rights.
(2 pages)